Basic research later uncovered potent anti-fibrosis [20], anti-inflammatory [21], or anti-oxidative effects [22] of mineralocorticoid receptor blockade in non-epithelial tissues which may not only be beneficial in heart failure, but also in chronic kidney disease (CKD) [23]. The gene discussed is NR3C2; the disease is chronic kidney disease.